SANOFI DENIES FDA ASKING FOR ACOMPLIA SAFETY DATA FROM DIET DRUG SALES IN EUROPE

While Sanofi-Aventis is busily gathering data on patient use of diet drug Acomplia in Europe to track side effects that may emerge during its initial months of sale, the company denied Oct. 6 that FDA has asked for more safety data as it weighs approving the diet pill for sale in the United States. Acomplia Report (http://www.acompliareport.com/News/news-100806.htm)